Braze , Inc. (NASDAQ:BRZE), a customer engagement software provider, finds itself at a pivotal juncture as it navigates a challenging macroeconomic environment while capitalizing on the burgeoning ...
Zoetis Inc. today announced that it has updated the U.S. label for Librela® (bedinvetmab injection), following its submission of a supplement to the U.S. Food and Drug Administration (FDA). This ...